# FDA Inspection 1180602 - Robins, Edwin MD, PS - September 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/bc1e8e8c-bac4-4ee0-bb02-c1faad77e8f6
Source feed: FDA_Inspections

> FDA Inspection 1180602 for Robins, Edwin MD, PS on September 13, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180602
- Company Name: Robins, Edwin MD, PS
- Inspection Date: 2022-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1273223 - 2025-06-13](https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/aa41f140-4afd-463c-8109-463eed654d47)
- [FDA Inspection 1273223 - 2025-06-13](https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/6bc521fb-ca08-4b68-988c-5df038a3608a)
- [FDA Inspection 1180602 - 2022-09-13](https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/917e2685-b27e-4837-9cc2-0f1484abb3cf)
- [FDA Inspection 1180602 - 2022-09-13](https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/629d37b9-cff5-4eaa-a1d2-2d28b5d93824)
- [FDA Inspection 1006801 - 2017-04-12](https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/6747c688-0e97-4935-bbd1-92a4941c4533)

Company: https://www.keypedia.com/companies/robins-edwin-md-ps/fa688efb-6471-442e-b77a-a1f717b96490

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d